Biotech’s biggest unicorn is now worth $7.5 billion
The financing comes as Moderna burns through about $450 million a year in an effort to craft medicines that can transform the body's cells into drug factories.
Moderna Therapeutics, a multibillion-dollar biotech startup, is raising $500 million in a round that values the company at $7.5 billion, according to the data provider Pitchbook.
The financing, first reported by Bloomberg, comes as Moderna burns through about $450 million a year in an effort to craft medicines that can transform
